Giladi Moshe bought NVCR
February 27, 2024 · Form 4 insider transaction
Giladi Moshe bought 51,124 shares of NovoCure Limited at $16.30 per share, a transaction worth $833.3K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
51,124
Price
$16.30
Total value
$833.3K
InsiderGiladi Moshe
RoleOfficer
CompanyNovoCure Limited (NVCR)
SecurityOrdinary Shares
Transaction codeA: Grant or award
Transaction dateFebruary 27, 2024
Filing dateFebruary 29, 2024
Shares owned after69,771
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents restricted share units that are scheduled to vest in equal installments on February 27, 2025, 2026 and 2027, subject to the reporting person's continued employment through such dates.